缺血性卒中预防中抗血小板药抵抗的应对策略

被引：2

作者：

马启荣

王雁

机构：

[1] 青岛大学附属医院神经内科

来源：

国际脑血管病杂志 | 2017年 / 25卷 / 12期

关键词：

卒中; 脑缺血; 抗血小板聚集药; 阿司匹林; 氯吡格雷; 抗药性;

D O I：

暂无

中图分类号：

R743.3 [急性脑血管疾病（中风）];

学科分类号：

1002 ;

摘要：

阿司匹林和氯吡格雷被广泛应用于心脑血管病的防治。尽管部分患者接受抗血小板治疗,但仍会经历缺血性事件,这种现象被称为抗血小板药物抵抗。文章对缺血性卒中预防中抗血小板药物抵抗的应对策略进行了综述。

引用

页码：1123 / 1127

页数：5

共 23 条

[1]

维持性血液透析患者阿司匹林抵抗的发生率及相关因素[J]. 张春华,崔太根,赵素梅,王世相,张小东.中华内科杂志. 2014 (03)

[2] Associations of P2Y12R gene polymorphisms with susceptibility to coronary heart disease and clinical efficacy of antiplatelet treatment with clopidogrel [J].

Yang, Hong-Hui ;

Chen, Yan ;

Gao, Chuan-Yu .

CARDIOVASCULAR THERAPEUTICS, 2016, 34 (06) :460-467

[3] Does high serum uric acid level cause aspirin resistance? [J].

Yildiz, Bekir S. ;

Ozkan, Emel ;

Esin, Fatma ;

Alihanoglu, Yusuf I. ;

Ozkan, Hayrettin ;

Bilgin, Murat ;

Kilic, Ismail D. ;

Ergin, Ahmet ;

Kaftan, Havane A. ;

Evrengul, Harun .

BLOOD COAGULATION & FIBRINOLYSIS, 2016, 27 (04) :412-418

[4]

Prasugrel in Clopidogrel Nonresponders Undergoing Percutaneous Coronary Intervention[J] . Renato Valenti,Rossella Marcucci,Vincenzo Comito,Marco Marrani,Giulia Cantini,Angela Migliorini,Guido Parodi,Gian Franco Gensini,Rosanna Abbate,David Antoniucci.JACC: Cardiovascular Interventions . 2015 (12)

[5] Risk factors for clopidogrel resistance in patients with ischemic cerebral infarction and the correlation with ABCB1 gene rs1045642 polymorphism [J].

Su, Jun-Feng ;

Hu, Xiao-Hui ;

Li, Cheng-Yan .

EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2015, 9 (01) :267-271

[6]

Multiple daily doses of acetyl‐salicylic acid (ASA) overcome reduced platelet response to once‐daily ASA after coronary artery bypass graft surgery: a pilot randomized controlled trial[J] . J. S. Paikin,J. Hirsh,J. S. Ginsberg,J. I. Weitz,N. C. Chan,R. P. Whitlock,G. Pare,M. Johnston,J. W. Eikelboom.J Thromb Haemost . 2015 (3)

[7]

Laboratory Aspirin Resistance Reversibility in Diabetic Patients: a Pilot Study Using Different Pharmaceutical Formulations[J] . Roberto Grimaldi,Marta Bisi,Enrica Lonni,Eloise Beggiato,Alessandra Valpreda,Marco Francesco Lococo,Enrico Dosio,Davide Giacomo Presutti,Milena Tagliabue,Fiorenzo Gaita.Cardiovascular Drugs and Therapy . 2014 (4)

[8] Non-HDL cholesterol is an independent risk factor for aspirin resistance in obese patients with type 2 diabetes [J].